AstraZeneca PLC
USD176.28
-1.17 (-0.66%)
CEO
Pascal Claude Roland Soriot
IPO Date
1993-05-12
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
GB
Open
$174.60
Prev. Close
$177.45
Day Low
$174.60
Day High
$177.56
52W Low
$137.22
52W High
$212.71
Market Cap
$273.38B
Volume
2.17M
| 29.5 |
| 31 Dec 2023 | FY | 82.4% | 13.0% | 15.2% | 5.9% | 0.73 | 0.82 | 35.4 |
| 31 Dec 2022 | FY | 72.1% | 7.4% | 8.9% | 3.4% | 0.79 | 0.86 | 64.3 |
| 31 Dec 2021 | FY | 66.8% | 0.3% | 0.3% | 0.1% | 0.78 | 1.16 | 1475.0 |
| 31 Dec 2020 | FY | 80.1% | 12.0% | 20.5% | 4.8% | 1.30 | 0.96 | 41.0 |
| 31 Dec 2019 | FY | 79.8% | 5.5% | 10.2% | 2.2% | 1.39 | 0.86 | 97.2 |
| 31 Dec 2018 | FY | 77.7% | 9.8% | 17.3% | 3.6% | 1.53 | 0.96 | 44.7 |
| 31 Dec 2017 | FY | 80.8% | 13.4% | 20.1% | 4.7% | 1.19 | 0.80 | 29.9 |
| 31 Dec 2016 | FY | 82.1% | 15.2% | 23.6% | 5.6% | 1.13 | 0.87 | 19.8 |
| 23.2 |
| 30 Jun 2025 | Q2 | 75.2% | 16.9% | 5.6% | 2.2% | 0.73 | 0.86 | 21.4 |
| 30 Mar 2025 | Q1 | 76.4% | 21.5% | 7.3% | 2.8% | 0.76 | 0.90 | 18.8 |
| 31 Dec 2024 | Q4 | 81.7% | 10.1% | 3.7% | 1.4% | 0.74 | 0.93 | 33.8 |
| 30 Sept 2024 | Q3 | 77.3% | 10.5% | 3.5% | 1.4% | 0.78 | 0.93 | 42.1 |
| 30 Jun 2024 | Q2 | 83.1% | 14.9% | 4.9% | 1.8% | 0.85 | 0.89 | 31.4 |
| 31 Mar 2024 | Q1 | 75.2% | 17.2% | 5.8% | 2.1% | 0.89 | 0.89 | 23.9 |
| 31 Dec 2023 | Q4 | 80.8% | 8.0% | 2.5% | 0.9% | 0.73 | 0.82 | 54.3 |
| 30 Sept 2023 | Q3 | 81.8% | 12.0% | 3.7% | 1.4% | 0.77 | 0.79 | 38.4 |